The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease

Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management

(2014) D. Rampton et al.   HAEMATOLOGICA

Hypersensitivity from Intravenous Iron Products

(2014) Andreas J. Bircher et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia

(2014) I. C. Macdougall et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min

(2013) Michael Auerbach et al.   AMERICAN JOURNAL OF HEMATOLOGY

Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron

(2013) Saroj Vadhan-Raj et al.   AMERICAN JOURNAL OF HEMATOLOGY

Serum Hepcidin in Inflammatory Bowel Diseases

(2013) Gaetano Bergamaschi et al.   INFLAMMATORY BOWEL DISEASES

Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia

(2012) David B. Bregman et al.   AMERICAN JOURNAL OF HEMATOLOGY

Ferric Carboxymaltose Prevents Recurrence of Anemia in Patients With Inflammatory Bowel Disease

(2012) Rayko Evstatiev et al.   Clinical Gastroenterology and Hepatology

Tolerability of different oral iron supplements: a systematic review

(2012) María Jesús Cancelo-Hidalgo et al.   CURRENT MEDICAL RESEARCH AND OPINION

Ferrous versus Ferric Oral Iron Formulations for the Treatment of Iron Deficiency: A Clinical Overview

(2012) Palacios Santiago   TheScientificWorldJOURNAL

High Prevalence but Insufficient Treatment of Iron-Deficiency Anemia in Patients with Inflammatory Bowel Disease: Results of a Population-Based Cohort

(2012) Claudia Ott et al.   Gastroenterology Research and Practice

Rethinking Iron Regulation and Assessment in Iron Deficiency, Anemia of Chronic Disease, and Obesity: Introducing Hepcidin

(2012) Lisa Tussing-Humphreys et al.   Journal of the Academy of Nutrition and Dietetics

Iron Status and Analysis of Efficacy and Safety of Ferric Carboxymaltose Treatment in Patients with Inflammatory Bowel Disease

(2011) Florian Beigel et al.   DIGESTION

Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease

(2011) Pantelis Oustamanolakis et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease

(2011) Rayko Evstatiev et al.   GASTROENTEROLOGY

Guidelines for the management of iron deficiency anaemia

(2011) A. F. Goddard et al.   GUT

Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease

(2011) James R. Goodhand et al.   INFLAMMATORY BOWEL DISEASES

The Pharmacokinetics and Pharmacodynamics of Iron Preparations

(2011) Peter Geisser et al.   Pharmaceutics

Serum Prohepcidin Levels in Children with Solid Tumors, Inflammatory Bowel Disease and Iron Deficiency Anemia

(2010) Z. Kaya et al.   JOURNAL OF TROPICAL PEDIATRICS

Treatment of iron deficiency anemia associated with gastrointestinal tract diseases

(2010) Ulas D Bayraktar   WORLD JOURNAL OF GASTROENTEROLOGY

Iron absorption and iron status are reduced after Roux-en-Y gastric bypass

(2009) Manuel Ruz et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Ferric Carboxymaltose

(2009) Katherine A. Lyseng-Williamson et al.   DRUGS

Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2

(2009) I. De Domenico et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study

(2009) Stefan Lindgren et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Common Misconceptions in the Diagnosis and Management of Anemia in Inflammatory Bowel Disease

(2008) Javier P Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial

(2008) Stefanie Kulnigg et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Ironing out the mechanism of anemia in celiac disease

(2008) C. Hershko et al.   HAEMATOLOGICA